{"DataElement":{"publicId":"6765924","version":"1","preferredName":"Major Comorbidity Disease Name","preferredDefinition":"The name of the major coexisting abnormal condition(s) of the body.","longName":"MAJ_COMBID_DZ_NAME","context":"MCL","contextVersion":"1","DataElementConcept":{"publicId":"6765792","version":"1","preferredName":"Major Comorbidity Disease or Disorder","preferredDefinition":"Greater or bigger in amount, extent, or size._The coexistence of two or more disease processes._Any abnormal condition of the body or mind that causes discomfort, dysfunction, or distress to the person affected or those in contact with the person. The term is often used broadly to include injuries, disabilities, syndromes, symptoms, deviant behaviors, and atypical variations of structure and function.","longName":"6765790v1.0:2239878v1.0","context":"MCL","contextVersion":"1","ObjectClass":{"publicId":"6765790","version":"1","preferredName":"Major Comorbidity","preferredDefinition":"Greater or bigger in amount, extent, or size.:The coexistence of two or more disease processes.","longName":"C45368:C16457","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Major","conceptCode":"C45368","definition":"Greater or bigger in amount, extent, or size.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Comorbidity","conceptCode":"C16457","definition":"The coexistence of two or more disease processes.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"899006C8-3AE4-17BF-E053-F662850AC498","latestVersionIndicator":"Yes","beginDate":"2019-05-23","endDate":null,"createdBy":"TAYLORT","dateCreated":"2019-05-23","modifiedBy":"ONEDATA","dateModified":"2019-05-23","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"2239878","version":"1","preferredName":"Diseases and Disorders","preferredDefinition":"A definite pathologic process with a characteristic set of signs and symptoms. It may affect the whole body or any of its parts, and its etiology, pathology, and prognosis may be known or unknown.","longName":"C2991","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Disease or Disorder","conceptCode":"C2991","definition":"Any abnormal condition of the body or mind that causes discomfort, dysfunction, or distress to the person affected or those in contact with the person. The term is often used broadly to include injuries, disabilities, syndromes, symptoms, deviant behaviors, and atypical variations of structure and function.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"F9FA7953-827F-043D-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-06-24","endDate":null,"createdBy":"REEVESD","dateCreated":"2005-06-24","modifiedBy":"ONEDATA","dateModified":"2005-06-24","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008537","version":"1","preferredName":"Diagnosis","preferredDefinition":"the process of identifying a disease by the signs and symptoms (NCI Glossary).","longName":"DX","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B205508C-8324-69B0-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-17","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-17","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"MCL:Molecular and Cellular Characterization of Screened Lesions","workflowStatus":"RELEASED","registrationStatus":"Application","id":"899006C8-3AF2-17BF-E053-F662850AC498","latestVersionIndicator":"Yes","beginDate":"2019-05-23","endDate":null,"createdBy":"TAYLORT","dateCreated":"2019-05-23","modifiedBy":"KNABLEJ","dateModified":"2022-03-03","changeDescription":"3/3/22 jk released as part of quarterly content review and prior reviews with SMEs.  5-23-19 tt created for Breast initial diagnosis module.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"6765796","version":"1","preferredName":"Comorbidity Disease or Disorder Name","preferredDefinition":"The coexistence of two or more disease processes._Any abnormal condition of the body or mind that causes discomfort, dysfunction, or distress to the person affected or those in contact with the person. The term is often used broadly to include injuries, disabilities, syndromes, symptoms, deviant behaviors, and atypical variations of structure and function._The words or language units by which a thing is known.","longName":"6765796v1.0","context":"MCL","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":null,"maxLength":"30","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"Liver disease","valueDescription":"Liver and Biliary Tract Disorder","ValueMeaning":{"publicId":"2581086","version":"1","preferredName":"Liver and Biliary Tract Disorder","longName":"2581086","preferredDefinition":"A non-neoplastic or neoplastic disorder that affects the liver, bile ducts, and gallbladder. Representative examples of non-neoplastic disorders include hepatitis, cirrhosis, cholangitis, and cholecystitis. Representative examples of neoplastic disorders include hepatocellular adenoma, hepatocellular carcinoma, and cholangiocarcinoma.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Hepatobiliary Disorder","conceptCode":"C3959","definition":"A non-neoplastic or neoplastic disorder that affects the liver, bile ducts, and gallbladder. Representative examples of non-neoplastic disorders include hepatitis, cirrhosis, cholangitis, and cholecystitis. Representative examples of neoplastic disorders include hepatocellular adenoma, hepatocellular carcinoma, and cholangiocarcinoma.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE88-09CB-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-04-05","endDate":null,"createdBy":"REEVESD","dateCreated":"2006-04-05","modifiedBy":"HARTLEYG","dateModified":"2019-05-23","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"899006C8-3B45-17BF-E053-F662850AC498","beginDate":"2019-05-23","endDate":null,"createdBy":"TAYLORT","dateCreated":"2019-05-23","modifiedBy":"ONEDATA","dateModified":"2019-05-23","deletedIndicator":"No"},{"value":"Kidney disease","valueDescription":"Renal Disorder","ValueMeaning":{"publicId":"2975595","version":"1","preferredName":"Renal Disorder","longName":"2975595","preferredDefinition":"A neoplastic or non-neoplastic condition affecting the kidney. Representative examples of non-neoplastic conditions include glomerulonephritis and nephrotic syndrome. Representative examples of neoplastic conditions include benign processes (e.g., renal lipoma and renal fibroma) and malignant processes (e.g., renal cell carcinoma and renal lymphoma).","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Kidney Disorder","conceptCode":"C3149","definition":"A neoplastic or non-neoplastic condition affecting the kidney. Representative examples of non-neoplastic conditions include glomerulonephritis and nephrotic syndrome. Representative examples of neoplastic conditions include benign processes (e.g., renal lipoma and renal fibroma) and malignant processes (e.g., renal cell carcinoma and renal lymphoma).","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"7C084539-0EDE-6AD0-E040-BB89AD43189B","latestVersionIndicator":"Yes","beginDate":"2009-12-31","endDate":null,"createdBy":"REEVESD","dateCreated":"2009-12-31","modifiedBy":"SOKKERL","dateModified":"2023-10-22","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"899006C8-3B5A-17BF-E053-F662850AC498","beginDate":"2019-05-23","endDate":null,"createdBy":"TAYLORT","dateCreated":"2019-05-23","modifiedBy":"ONEDATA","dateModified":"2019-05-23","deletedIndicator":"No"},{"value":"Diabetes","valueDescription":"Diabetes Mellitus","ValueMeaning":{"publicId":"3292684","version":"1","preferredName":"Diabetes Mellitus","longName":"3292684","preferredDefinition":"A metabolic disorder characterized by abnormally high blood sugar levels due to diminished production of insulin or insulin resistance/desensitization.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Diabetes Mellitus","conceptCode":"C2985","definition":"A metabolic disorder characterized by abnormally high blood sugar levels due to diminished production of insulin or insulin resistance/desensitization.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"AEA65AE0-D82E-3EBD-E040-BB89AD431EBC","latestVersionIndicator":"Yes","beginDate":"2011-10-06","endDate":null,"createdBy":"COOPERM","dateCreated":"2011-10-06","modifiedBy":"SOKKERL","dateModified":"2023-10-22","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"899006C8-3B65-17BF-E053-F662850AC498","beginDate":"2019-05-23","endDate":null,"createdBy":"TAYLORT","dateCreated":"2019-05-23","modifiedBy":"ONEDATA","dateModified":"2019-05-23","deletedIndicator":"No"},{"value":"Heart disease","valueDescription":"Heart Disorder","ValueMeaning":{"publicId":"3181118","version":"1","preferredName":"Heart Disorder","longName":"3181118","preferredDefinition":"A non-neoplastic or neoplastic disorder that affects the heart and/or the pericardium. Representative examples include endocarditis, pericarditis, atrial myxoma, cardiac myeloid sarcoma, and pericardial malignant mesothelioma.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Heart Disorder","conceptCode":"C3079","definition":"A non-neoplastic or neoplastic disorder that affects the heart and/or the pericardium. Representative examples include endocarditis, pericarditis, atrial myxoma, cardiac myeloid sarcoma, and pericardial malignant mesothelioma.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"991CC1A7-5429-0D9B-E040-BB89AD4320EF","latestVersionIndicator":"Yes","beginDate":"2011-01-05","endDate":null,"createdBy":"LUY","dateCreated":"2011-01-05","modifiedBy":"SOKKERL","dateModified":"2023-10-22","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"899006C8-3B70-17BF-E053-F662850AC498","beginDate":"2019-05-23","endDate":null,"createdBy":"TAYLORT","dateCreated":"2019-05-23","modifiedBy":"ONEDATA","dateModified":"2019-05-23","deletedIndicator":"No"},{"value":"Obesity","valueDescription":"Obesity","ValueMeaning":{"publicId":"2566203","version":"1","preferredName":"Obesity","longName":"2566203","preferredDefinition":"Having a high amount of body fat (body mass index [BMI] of 30 or more).","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Obesity","conceptCode":"C3283","definition":"Having a high amount of body fat (body mass index [BMI] of 30 or more).","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-CFA8-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2003-07-23","endDate":null,"createdBy":"CHANGM","dateCreated":"2003-07-23","modifiedBy":"CURTIST","dateModified":"2011-04-13","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"899006C8-3B7B-17BF-E053-F662850AC498","beginDate":"2019-05-23","endDate":null,"createdBy":"TAYLORT","dateCreated":"2019-05-23","modifiedBy":"ONEDATA","dateModified":"2019-05-23","deletedIndicator":"No"},{"value":"Anemia","valueDescription":"Anemia","ValueMeaning":{"publicId":"4291759","version":"1","preferredName":"Anemia","longName":"4291759","preferredDefinition":"A reduction in the number of red blood cells, the amount of hemoglobin, and/or the volume of packed red blood cells. Clinically, anemia represents a reduction in the oxygen-transporting capacity of a designated volume of blood, resulting from an imbalance between blood loss (through hemorrhage or hemolysis) and blood production. Signs and symptoms of anemia may include pallor of the skin and mucous membranes, shortness of breath, palpitations of the heart, soft systolic murmurs, lethargy, and fatigability.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Anemia","conceptCode":"C2869","definition":"A reduction in the number of red blood cells, the amount of hemoglobin, and/or the volume of packed red blood cells. Clinically, anemia represents a reduction in the oxygen-transporting capacity of a designated volume of blood, resulting from an imbalance between blood loss (through hemorrhage or hemolysis) and blood production. Signs and symptoms of anemia may include pallor of the skin and mucous membranes, shortness of breath, palpitations of the heart, soft systolic murmurs, lethargy, and fatigability.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F8ABEA26-6419-ED7C-E040-BB89AD4312B2","latestVersionIndicator":"Yes","beginDate":"2014-05-05","endDate":null,"createdBy":"SORENSENS","dateCreated":"2014-05-05","modifiedBy":"ONEDATA_WA","dateModified":"2023-05-01","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"899006C8-3B86-17BF-E053-F662850AC498","beginDate":"2019-05-23","endDate":null,"createdBy":"TAYLORT","dateCreated":"2019-05-23","modifiedBy":"ONEDATA","dateModified":"2019-05-23","deletedIndicator":"No"},{"value":"Data not available","valueDescription":"Source Data Not Available","ValueMeaning":{"publicId":"4842575","version":"1","preferredName":"Source Data Not Available","longName":"4842575","preferredDefinition":"Data from an original source is not present, accessible or ready for use or service.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Source Data Not Available","conceptCode":"C67329","definition":"Data from an original source is not present, accessible or ready for use or service.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"173BF844-9709-E098-E050-BB89AD431F3E","latestVersionIndicator":"Yes","beginDate":"2015-05-29","endDate":null,"createdBy":"LEEW","dateCreated":"2015-05-29","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8B86F70B-AF43-6462-E053-F662850AF54D","beginDate":"2019-06-17","endDate":null,"createdBy":"TAYLORT","dateCreated":"2019-06-17","modifiedBy":"ONEDATA","dateModified":"2019-06-17","deletedIndicator":"No"},{"value":"Unknown","valueDescription":"Unknown","ValueMeaning":{"publicId":"5682944","version":"1","preferredName":"Unknown","longName":"5682944","preferredDefinition":"Not known, not observed, not recorded, or refused.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Unknown","conceptCode":"C17998","definition":"Not known, observed, recorded; or reported as unknown by the data contributor.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"498B0E12-9AE5-79DC-E053-F662850A0B75","latestVersionIndicator":"Yes","beginDate":"2017-02-27","endDate":null,"createdBy":"ALEYR","dateCreated":"2017-02-27","modifiedBy":"GDEEN","dateModified":"2023-12-18","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8B86F70B-AF4D-6462-E053-F662850AF54D","beginDate":"2019-06-17","endDate":null,"createdBy":"TAYLORT","dateCreated":"2019-06-17","modifiedBy":"ONEDATA","dateModified":"2019-06-17","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008537","version":"1","preferredName":"Diagnosis","preferredDefinition":"the process of identifying a disease by the signs and symptoms (NCI Glossary).","longName":"DX","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B205508C-8324-69B0-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-17","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-17","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"6765795","version":"1","preferredName":"Comorbidity Disease or Disorder Name","preferredDefinition":"The coexistence of two or more disease processes.:Any abnormal condition of the body or mind that causes discomfort, dysfunction, or distress to the person affected or those in contact with the person. The term is often used broadly to include injuries, disabilities, syndromes, symptoms, deviant behaviors, and atypical variations of structure and function.:The words or language units by which a thing is known.","longName":"C16457:C2991:C42614","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Comorbidity","conceptCode":"C16457","definition":"The coexistence of two or more disease processes.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Disease or Disorder","conceptCode":"C2991","definition":"Any abnormal condition of the body or mind that causes discomfort, dysfunction, or distress to the person affected or those in contact with the person. The term is often used broadly to include injuries, disabilities, syndromes, symptoms, deviant behaviors, and atypical variations of structure and function.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Name","conceptCode":"C42614","definition":"The words or language units by which a thing is known.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"899006C8-3B12-17BF-E053-F662850AC498","latestVersionIndicator":"Yes","beginDate":"2019-05-23","endDate":null,"createdBy":"TAYLORT","dateCreated":"2019-05-23","modifiedBy":"ONEDATA","dateModified":"2019-05-23","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"MCL:Molecular and Cellular Characterization of Screened Lesions","workflowStatus":"RELEASED","registrationStatus":"Application","id":"899006C8-3B23-17BF-E053-F662850AC498","latestVersionIndicator":"Yes","beginDate":"2019-05-23","endDate":null,"createdBy":"TAYLORT","dateCreated":"2019-05-23","modifiedBy":"KNABLEJ","dateModified":"2022-03-03","changeDescription":"3/3/22 jk released as part of quarterly content review and prior reviews with SMEs.  5-23-19 tt created for Breast initial diagnosis module.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"5506112","version":"1","longName":"Breast","context":"MCL","ClassificationSchemeItems":[{"publicId":"6643181","version":"1","longName":"Initial Diagnosis","context":"MCL"}]}],"AlternateNames":[],"ReferenceDocuments":[{"name":"Major comorbid conditions","type":"Preferred Question Text","description":"Major comorbid conditions","url":null,"context":"MCL"}],"origin":"MCL:Molecular and Cellular Characterization of Screened Lesions","workflowStatus":"RELEASED","registrationStatus":"Application","id":"899247F6-5AB3-6D3E-E053-F662850AA0E1","latestVersionIndicator":"Yes","beginDate":"2019-05-23","endDate":null,"createdBy":"TAYLORT","dateCreated":"2019-05-23","modifiedBy":"KNABLEJ","dateModified":"2022-03-03","changeDescription":"3/3/22 jk released as part of quarterly content review and prior reviews with SMEs.  5-23-19 tt created for Breast initial diagnosis module.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}